1 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Study of CLN-619 Alone and in Combination With Pembrolizumab in Advanced Solid Tumorsnon-small cell lung carcinomaActive, not recruitingPhase 12025-11-24NCT05117476